Cargando…
Clinically practical pharmacometrics computer model to evaluate and personalize pharmacotherapy in pediatric rare diseases: application to Graves' disease
OBJECTIVES: Graves' disease (GD) with onset in childhood or adolescence is a rare disease (ORPHA:525731). Current pharmacotherapeutic approaches use antithyroid drugs, such as carbimazole, as monotherapy or in combination with thyroxine hormone substitutes, such as levothyroxine, as block-and-r...
Autores principales: | Steffens, Britta, Koch, Gilbert, Gächter, Pascal, Claude, Fabien, Gotta, Verena, Bachmann, Freya, Schropp, Johannes, Janner, Marco, l'Allemand, Dagmar, Konrad, Daniel, Welzel, Tatjana, Szinnai, Gabor, Pfister, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188966/ https://www.ncbi.nlm.nih.gov/pubmed/37206476 http://dx.doi.org/10.3389/fmed.2023.1099470 |
Ejemplares similares
-
FRI478 Pharmacometrics-based Computer Model Utilizing Heart Rate To Monitor Thyroid Function In Children With Graves' Disease
por: Steffens, Britta, et al.
Publicado: (2023) -
Modeling of levothyroxine in newborns and infants with congenital hypothyroidism: challenges and opportunities of a rare disease multi-center study
por: Koch, Gilbert, et al.
Publicado: (2021) -
MON-102 Serum Concentrations of FT4 and TSH in the First Six Months of L-Thyroxine Treatment in Infants with Congenital Hypothyroidism: Target Attainment Rates Should Be Improved
por: Leroux, Stéphanie, et al.
Publicado: (2020) -
MON-081 Mathematical Modeling of Residual Endogenous FT4 Synthesis and Exogenous L-Thyroxine Administration over the First 2 Years of Life in Infants with Congenital Hypothyroidism
por: Leroux, Stéphanie, et al.
Publicado: (2020) -
OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
por: Bachmann, Freya, et al.
Publicado: (2021)